Theme: RECAMO2020: through Cancer Research towards Applied Molecular Oncology III
Reviews
Klin Onkol 2019; 32(Suppl 3): 6-12.
DOI: 10.14735/amko20193S6.
Keywords: non-small cell lung cancer – epidermal growth factor receptor – tyrosine kinase inhibitors – molecular targeted therapy – EGFR mutations
Authors: Bílek Ondřej, Holánek Miloš, Berkovcová Jitka, Horký Ondřej, Kazda Tomáš, Čoupková Helena, Špelda Stanislav, Kristková Lenka, Zvaríková Mária, Podhorec Ján, Bořilová Simona, Bohovicová Lucia, Zdražilová Dubská Lenka2019-10-14:Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment
Keywords: non-small cell lung cancer – epidermal growth factor receptor – tyrosine kinase inhibitors – molecular targeted therapy – EGFR mutations
Authors: Bílek Ondřej, Holánek Miloš, Berkovcová Jitka, Horký Ondřej, Kazda Tomáš, Čoupková Helena, Špelda Stanislav, Kristková Lenka, Zvaríková Mária, Podhorec Ján, Bořilová Simona, Bohovicová Lucia, Zdražilová Dubská Lenka2019-10-14:Uncommon EGFR Mutations in Non-Small Cell Lung Cancer and Their Impact on the Treatment
Klin Onkol 2019; 32(Suppl 3): 13-18.
DOI: 10.14735/amko20193S13.
Keywords: CRISPR-Cas9 – immunotherapy – clinical trial
Authors: Zatloukalová Pavlína, Krejčíř Radovan, Valík Dalibor, Vojtěšek Bořivoj2019-10-14:CRISPR-Cas9 as a Tool in Cancer Therapy
Keywords: CRISPR-Cas9 – immunotherapy – clinical trial
Authors: Zatloukalová Pavlína, Krejčíř Radovan, Valík Dalibor, Vojtěšek Bořivoj2019-10-14:CRISPR-Cas9 as a Tool in Cancer Therapy
Klin Onkol 2019; 32(Suppl 3): 19-24.
DOI: 10.14735/amko20193S19.
Keywords: synthetic lethality – PARP inhibitors – olaparib – BRCAness – DNA repair
Authors: Bortlíková Lucie, Müller Petr, Vojtěšek Bořivoj, Rak Vladimír, Svoboda Marek2019-10-14:Synthetic Lethality – Its Current Application and Potential in Oncological Treatment
Keywords: synthetic lethality – PARP inhibitors – olaparib – BRCAness – DNA repair
Authors: Bortlíková Lucie, Müller Petr, Vojtěšek Bořivoj, Rak Vladimír, Svoboda Marek2019-10-14:Synthetic Lethality – Its Current Application and Potential in Oncological Treatment
Klin Onkol 2019; 32(Suppl 3): 25-33.
DOI: 10.14735/amko20193S25.
Keywords: cancer – chemotherapy – drugs – organometallic compounds – titanium – ruthenium
Authors: Skoupilová Hana, Hrstka Roman2019-10-14:Progress in the Utilisation of Organometallic Compounds in the Development of Cancer Drugs
Keywords: cancer – chemotherapy – drugs – organometallic compounds – titanium – ruthenium
Authors: Skoupilová Hana, Hrstka Roman2019-10-14:Progress in the Utilisation of Organometallic Compounds in the Development of Cancer Drugs
Klin Onkol 2019; 32(Suppl 3): 34-38.
DOI: 10.14735/amko20193S34.
Keywords: signal transduction – breast neoplasms – oestrogen receptors
Authors: Voňka Petr, Hrstka Roman2019-10-14:Overview of Current Findings about the Role of Oestrogen Receptor α in Cancer Cell Signalling Pathways
Keywords: signal transduction – breast neoplasms – oestrogen receptors
Authors: Voňka Petr, Hrstka Roman2019-10-14:Overview of Current Findings about the Role of Oestrogen Receptor α in Cancer Cell Signalling Pathways
Klin Onkol 2019; 32(Suppl 3): 39-45.
DOI: 10.14735/amko20193S39.
Keywords: glycoproteins – serum – biomarkers – cancer
Authors: Hernychová Lenka, Uhrík Lukáš, Nenutil Rudolf, Novotný Miloš2019-10-14:Glycoproteins in the Sera of Oncological Patients
Keywords: glycoproteins – serum – biomarkers – cancer
Authors: Hernychová Lenka, Uhrík Lukáš, Nenutil Rudolf, Novotný Miloš2019-10-14:Glycoproteins in the Sera of Oncological Patients
Klin Onkol 2019; 32(Suppl 3): 46-55.
DOI: 10.14735/amko20193S46.
Keywords: antibodies – glycosylation – pharmacology – immune system – therapeutics
Authors: Uhrík Lukáš, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Glycosylation as an Important Regulator of Antibody Function
Keywords: antibodies – glycosylation – pharmacology – immune system – therapeutics
Authors: Uhrík Lukáš, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Glycosylation as an Important Regulator of Antibody Function
Klin Onkol 2019; 32(Suppl 3): 56-64.
DOI: 10.14735/amko20193S56.
Keywords: ubiquitin – mass spectrometry – neoplasms – proteins – proteomics
Authors: Faktor Jakub, Pjechová Mariana, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Protein Ubiquitination Research in Oncology
Keywords: ubiquitin – mass spectrometry – neoplasms – proteins – proteomics
Authors: Faktor Jakub, Pjechová Mariana, Hernychová Lenka, Vojtěšek Bořivoj2019-10-14:Protein Ubiquitination Research in Oncology
Klin Onkol 2019; 32(Suppl 3): 65-71.
DOI: 10.14735/amko20193S65.
Keywords: long non-coding RNA – tumor biomarkers – carcinogenesis – biosensing techniques
Authors: Moráňová Ludmila, Bartošík Martin2019-10-14:Long Non-Coding RNAs – Current Methods of Detection and Clinical Applications
Keywords: long non-coding RNA – tumor biomarkers – carcinogenesis – biosensing techniques
Authors: Moráňová Ludmila, Bartošík Martin2019-10-14:Long Non-Coding RNAs – Current Methods of Detection and Clinical Applications
Klin Onkol 2019; 32(Suppl 3): 72-77.
DOI: 10.14735/amko20193S72.
Keywords: viry – virové proteiny – p53 – p63 – p73 – tumorigeneze
Authors: Brychtová Veronika, Hrabal Václav, Vojtěšek Bořivoj2019-10-14:Oncogenic Viral Protein Interactions with p53 Family Proteins
Keywords: viry – virové proteiny – p53 – p63 – p73 – tumorigeneze
Authors: Brychtová Veronika, Hrabal Václav, Vojtěšek Bořivoj2019-10-14:Oncogenic Viral Protein Interactions with p53 Family Proteins
Klin Onkol 2019; 32(Suppl 3): 78-85.
DOI: 10.14735/amko20193S78.
Keywords: genomics – transcriptomics – proteomics – bioinformatics – software development
Authors: Zavadil Kokáš Filip, Faktor Jakub, Vojtěšek Bořivoj2019-10-14:Cooperation of Genomic, Transcriptomics and Proteomic Methods in the Detection of Mutated Proteins
Keywords: genomics – transcriptomics – proteomics – bioinformatics – software development
Authors: Zavadil Kokáš Filip, Faktor Jakub, Vojtěšek Bořivoj2019-10-14:Cooperation of Genomic, Transcriptomics and Proteomic Methods in the Detection of Mutated Proteins
